multidisciplinary approach: managing cdk4/6 inhibitors
Published 5 years ago • 21 plays • Length 6:03Download video MP4
Download video MP3
Similar videos
-
6:03
multidisciplinary approach: managing cdk4/6 inhibitors
-
10:47
patient management of cdk 4/6 inhibitors
-
1:54
cell cycle inhibitors - cdk4/6 inhibitors
-
7:58
cdk 4/6 inhibitors: how are they used in metastatic breast cancer treatment?
-
3:05
multidisciplinary approach to managing oral oncolytics
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
7:13
the biological rationale for cdk4/6 inhibitors
-
7:18
kisqali (ribociclib): side effects and what to expect
-
24:24
palbociclib and letrozole for my metastatic breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
23:28
cdk4/6 inhibitors making the difference ” dr. ahmed saadeddin
-
13:05
expert perspectives: cdk 4/6 inhibitor therapy for er metastatic breast cancer
-
5:50
the efficacy and safety of cdk4/6 inhibitors
-
18:07
emerging evidence on the role of cdk4/6 inhibitors in early bc
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
8:28
cdk4/6 inhibition in breast cancer
-
17:00
treatment of disease progression after first line cdk4/6 inhibitors by dr. omalkhair abulkhair
-
5:16
the clinical potential of cdk4/6 inhibitors
-
1:17:18
changing standards of care for use of cdk4 and 6 inhibitors in the treatment of breast cancer
-
1:01
dr. richardson on the use of cdk4/6 inhibitors in hr /her2- breast cancer